Previous studies demonstrated that TOP2A was overexpressed in adrenocortical carcinoma and influenced tumor progression, because knockdown of TOP2A in adrenocortical carcinoma cells decreased cell proliferation and invasion. Here, TOP2A is linked to adrenal cortex carcinoma.